NCBI PubMed Central
open access
Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: A pilot single-arm trial.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Severe infections, domain-specific cognitive vulnerability, and future infection risk in older adults.#1175708
- The Role of Generative AI in Cognitive Diseases Diagnosis, Treatment Planning, and Future Healthcare / edited by Manish Dixit, Kirti Raj Bhatele, Mohammad Tauheed Ahmad, Devanshu Tiwari#1153990
- Daphnetin Capsule In the Treatment of VaScular COgnitive Impairment Without Dementia#994113
- Additional file 1 of Csf1r-mediated depletion of myeloid cells prevents dopaminergic neuron loss during chronic colitis#318799
- Editorial: The role of gut microbiota in immune-related inflammatory diseases#354158
Record · ID 1346689
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive